Lipid-lowering drug targets and lung related diseases: a Mendelian randomization study

Q1 Biochemistry, Genetics and Molecular Biology

Frontiers in Life Science Pub Date : 2024-03-12 DOI:10.1080/26895293.2024.2329440

Haifeng Yu, Xiaofei Zhang, Bian Wen, Shuo Hu, Bin Ni

引用次数: 0

Abstract

OBJECTIVES This genetics-based study aimed to evaluate the relationships of long-term lipid-lowering agents on lung-related diseases (LRD) outcomes.METHODS We extracted genetic variations of six dr...

查看原文本刊更多论文

降脂药物靶点与肺部相关疾病：孟德尔随机研究

目的这项基于遗传学的研究旨在评估长期服用降脂药对肺部相关疾病（LRD）结局的影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Frontiers in Life Science MULTIDISCIPLINARY SCIENCES-

CiteScore

5.50

自引率

0.00%

发文量

期刊介绍： Frontiers in Life Science publishes high quality and innovative research at the frontier of biology with an emphasis on interdisciplinary research. We particularly encourage manuscripts that lie at the interface of the life sciences and either the more quantitative sciences (including chemistry, physics, mathematics, and informatics) or the social sciences (philosophy, anthropology, sociology and epistemology). We believe that these various disciplines can all contribute to biological research and provide original insights to the most recurrent questions.